Molina reaffirms FY 2026 EPS guidance (GAAP ≥$3.20, adjusted ≥$5.00), sets Q1 call and Investor Day dates

MOLINA HEALTHCARE, INC.

Full-year 2026 GAAP diluted EPS guidance reaffirmed at at least $3.20.
Full-year 2026 adjusted diluted EPS guidance reaffirmed at at least $5.00.
Q1 2026 earnings due after close April 22; conference call April 23 at 8 a.m. ET.
Investor Day scheduled for May 8, 2026, starting at 9:30 a.m. ET.
Guidance aligns with prior outlook issued February 6, 2026; no change.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.